Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

295 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Noninvasive detection of subclinical coronary atherosclerosis coupled with assessment of changes in plaque characteristics using novel invasive imaging modalities: the Integrated Biomarker and Imaging Study (IBIS).
Van Mieghem CA, McFadden EP, de Feyter PJ, Bruining N, Schaar JA, Mollet NR, Cademartiri F, Goedhart D, de Winter S, Granillo GR, Valgimigli M, Mastik F, van der Steen AF, van der Giessen WJ, Sianos G, Backx B, Morel MA, van Es GA, Zalewski A, Serruys PW. Van Mieghem CA, et al. Among authors: van es ga, van der steen af, van der giessen wj. J Am Coll Cardiol. 2006 Mar 21;47(6):1134-42. doi: 10.1016/j.jacc.2005.09.075. Epub 2006 Feb 23. J Am Coll Cardiol. 2006. PMID: 16545642 Free article. Clinical Trial.
Sensitivity and specificity of QCA in detecting coronary arterial remodeling after intracoronary brachytherapy: a comparison to serial volumetric three-dimensional intravascular ultrasound analysis. Can we detect positive remodeling by luminography?
Kozuma K, Regar E, Bruining N, van der Giessen W, Boersma E, Foley DP, de Feyter PJ, Levendag PC, Serruys PW. Kozuma K, et al. J Invasive Cardiol. 2003 Nov;15(11):636-40. J Invasive Cardiol. 2003. PMID: 14608135
Very long sirolimus-eluting stent implantation for de novo coronary lesions.
Degertekin M, Arampatzis CA, Lemos PA, Saia F, Hoye A, Daemen J, Tanabe K, Lee CH, Hofma SJ, Sianos G, McFadden E, van der Giessen W, Smits PC, de Feyter PJ, van Domburg RT, Serruys PW. Degertekin M, et al. Am J Cardiol. 2004 Apr 1;93(7):826-9. doi: 10.1016/j.amjcard.2003.12.018. Am J Cardiol. 2004. PMID: 15050483 Free article. Clinical Trial.
Local intracoronary administration of antisense oligonucleotide against c-myc for the prevention of in-stent restenosis: results of the randomized investigation by the Thoraxcenter of antisense DNA using local delivery and IVUS after coronary stenting (ITALICS) trial.
Kutryk MJ, Foley DP, van den Brand M, Hamburger JN, van der Giessen WJ, deFeyter PJ, Bruining N, Sabate M, Serruys PW; ITALICS Trial. Kutryk MJ, et al. Among authors: van den brand m, van der giessen wj. J Am Coll Cardiol. 2002 Jan 16;39(2):281-7. doi: 10.1016/s0735-1097(01)01741-7. J Am Coll Cardiol. 2002. PMID: 11788220 Free article. Clinical Trial.
Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction.
Lemos PA, Saia F, Hofma SH, Daemen J, Ong AT, Arampatzis CA, Hoye A, McFadden E, Sianos G, Smits PC, van der Giessen WJ, de Feyter P, van Domburg RT, Serruys PW. Lemos PA, et al. Among authors: van domburg rt, van der giessen wj. J Am Coll Cardiol. 2004 Feb 18;43(4):704-8. doi: 10.1016/j.jacc.2003.12.022. J Am Coll Cardiol. 2004. PMID: 14975486 Free article. Clinical Trial.
Treatment of very small vessels with 2.25-mm diameter sirolimus-eluting stents (from the RESEARCH registry).
Lemos PA, Arampatzis CA, Saia F, Hoye A, Degertekin M, Tanabe K, Lee CH, Cummins P, Smits PC, McFadden E, Sianos G, de Feyter P, van der Giessen WJ, van Domburg RT, Serruys PW. Lemos PA, et al. Among authors: van domburg rt, van der giessen wj. Am J Cardiol. 2004 Mar 1;93(5):633-6. doi: 10.1016/j.amjcard.2003.11.037. Am J Cardiol. 2004. PMID: 14996597 Clinical Trial.
Incidence of thrombotic stent occlusion during the first three months after sirolimus-eluting stent implantation in 500 consecutive patients.
Regar E, Lemos PA, Saia F, Degertekin M, Tanabe K, Lee CH, Arampatzis CA, Hoye A, Sianos G, de Feyter P, van der Giessen WJ, Smits PC, van Domburg RT, Serruys PW. Regar E, et al. Among authors: van domburg rt, van der giessen wj. Am J Cardiol. 2004 May 15;93(10):1271-5. doi: 10.1016/j.amjcard.2004.02.013. Am J Cardiol. 2004. PMID: 15135702
Significant reduction in restenosis after the use of sirolimus-eluting stents in the treatment of chronic total occlusions.
Hoye A, Tanabe K, Lemos PA, Aoki J, Saia F, Arampatzis C, Degertekin M, Hofma SH, Sianos G, McFadden E, van der Giessen WJ, Smits PC, de Feyter PJ, van Domburg RT, Serruys PW. Hoye A, et al. Among authors: van domburg rt, van der giessen wj. J Am Coll Cardiol. 2004 Jun 2;43(11):1954-8. doi: 10.1016/j.jacc.2004.01.045. J Am Coll Cardiol. 2004. PMID: 15172397 Free article.
Restenosis rates following bifurcation stenting with sirolimus-eluting stents for de novo narrowings.
Tanabe K, Hoye A, Lemos PA, Aoki J, Arampatzis CA, Saia F, Lee CH, Degertekin M, Hofma SH, Sianos G, McFadden E, Smits PC, van der Giessen WJ, de Feyter P, van Domburg RT, Serruys PW. Tanabe K, et al. Among authors: van domburg rt, van der giessen wj. Am J Cardiol. 2004 Jul 1;94(1):115-8. doi: 10.1016/j.amjcard.2004.03.040. Am J Cardiol. 2004. PMID: 15219520
295 results